Swiss Re AG

Swiss Re AG Q3 2025 Earnings Recap

SREN.SW Q3 2025 November 15, 2025

Get alerts when SREN.SW reports next quarter

Set up alerts — free

Swiss Re reported strong financial results for the first nine months of 2025, achieving a net income of USD 4 billion and an annualized return on equity of 22.5%, while navigating the challenges in its Life & Health Re segment.

Market Reaction

1-Day -2.75%
5-Day -5.91%
30-Day -10.13%

See SREN.SW alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • The company benefited from low large claims, recording only USD 200 million in Q3, contributing to robust results in P&C Re and Corporate Solutions.
  • Despite a year-to-date net income of USD 4 billion, Swiss Re signals a likely miss of the USD 1.6 billion target for Life & Health Re due to underperformance in smaller portfolios.
  • New business CSM generation was USD 3.9 billion, slightly down from USD 4.2 billion last year, reflecting a disciplined underwriting approach amidst a challenging pricing environment.
  • P&C Re recorded a strong 71.3% combined ratio in Q3, well below the annual target of 85%, attributing this to favorable large loss experience and prudent reserve management.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit SREN.SW on AllInvestView.

Get the Full Picture on SREN.SW

Track Swiss Re AG in your portfolio with real-time analytics, dividend tracking, and more.

View SREN.SW Analysis